Back

Estimating The Incidence Of SARS-COV-2 Infections In 2020 In Belgium By Jointly Modelling Seroprevalence, Hospitalization And Mortality Data

Braeye, T.; De Pauw, R.; Geebelen, L.; Abrams, S.; Desombere, I.; Hens, N.; Hammami, N.; Roelants, M.; Herzog, S. A.

2025-07-03 epidemiology
10.1101/2025.07.02.25330709 medRxiv
Show abstract

BACKGROUNDThe incidence of SARS-CoV-2 infections was not directly observed during the pandemic. We estimated incidences and the associated burden, through the infection fatality rate (IFR) and infection hospitalization rate (IHR), by jointly modeling seroprevalence, hospitalization, and mortality data. METHODSWe used a hierarchical Bayesian model to fit a spline, representing incidence, to the observed number of hospitalizations, deaths and seroprevalence results. Two cross-sectional seroprevalence studies on the prevalence of SARS-CoV-2 antibodies in the general population collected 37,235 samples in the age interval 18 to 74 years across 30 time points between March 2020 and January 2021. One study analyzed residual laboratory samples with the Euroimmun Anti-SARS-CoV-2 ELISA. The other study analyzed blood donor samples with the Wantai Ab ELISA. Data on the sensitivity and specificity of the serological tests were obtained from published research. Time-varying IFR and IHR estimates and their associated delay distributions were estimated within the same model. RESULTSBy the end of January 2021, we estimated 19% (95%CrI 18%-21%), 13% (95%CrI 12%-15%) and 11% (95%CrI 8%-13%) of the Belgian 18-49, 50-64 and 65-74 year-olds to have been infected with SARS-CoV-2. Infections occurred in two large waves with few infections in between. The first wave mostly affected the younger age group, with a peak weekly incidence of 2.0% (95%CrI 1.7%-2.3%) end of March 2020, while weekly incidences were more comparable during the second wave end of October 2020: 1.6% (95%CrI 1.2%-2%) for 65-74 year-olds and 2.8% (95%CrI 2.3%-3.3%) for 18-49 year-olds. Both the hospitalization and fatality rates declined over time. Among persons aged 65 to 74 years the hospitalization rate declined from 9.9% (95%CrI 7.2-13.2) to 5.1% (95%CrI 3.2-6.3) and fatality rates from 2.8% (95%CrI 2.0%-3.8%) to 1.3% (95%CrI 0.9%-1.7%). IHR and IFR were considerably lower in the younger age groups. CONCLUSIONDuring 2020, an estimated 16.2% (95%CrI 15.1%-17.3%) of the Belgian adult population was infected with SARS-CoV-2. These infections occurred primarily in two waves, one in March and another one in October 2020, with minimal transmission in between. Severe disease was more prevalent among older age groups and earlier on in 2020.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
Eurosurveillance
80 papers in training set
Top 0.1%
52.2%
50% of probability mass above
2
International Journal of Epidemiology
74 papers in training set
Top 0.3%
6.4%
3
BMJ
49 papers in training set
Top 0.3%
3.6%
4
BMC Public Health
147 papers in training set
Top 2%
2.6%
5
The Lancet
16 papers in training set
Top 0.2%
2.1%
6
Nature Communications
4913 papers in training set
Top 47%
2.1%
7
BMC Infectious Diseases
118 papers in training set
Top 3%
1.7%
8
BMC Medicine
163 papers in training set
Top 4%
1.5%
9
American Journal of Epidemiology
57 papers in training set
Top 0.8%
1.5%
10
International Journal of Infectious Diseases
126 papers in training set
Top 2%
1.5%
11
European Journal of Public Health
20 papers in training set
Top 0.6%
1.3%
12
The Lancet Regional Health - Europe
32 papers in training set
Top 0.2%
1.3%
13
PLOS Medicine
98 papers in training set
Top 3%
1.2%
14
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.2%
15
Emerging Infectious Diseases
103 papers in training set
Top 2%
1.2%
16
Open Forum Infectious Diseases
134 papers in training set
Top 2%
1.2%
17
PLOS ONE
4510 papers in training set
Top 61%
1.1%
18
BMJ Open
554 papers in training set
Top 12%
0.9%
19
European Journal of Epidemiology
40 papers in training set
Top 0.7%
0.8%
20
Journal of Epidemiology and Community Health
32 papers in training set
Top 0.6%
0.8%
21
Frontiers in Medicine
113 papers in training set
Top 7%
0.7%
22
Journal of Infection
71 papers in training set
Top 3%
0.7%
23
The Lancet Infectious Diseases
71 papers in training set
Top 3%
0.7%
24
Epidemiology and Infection
84 papers in training set
Top 3%
0.7%
25
The Journal of Infectious Diseases
182 papers in training set
Top 6%
0.6%
26
Scientific Reports
3102 papers in training set
Top 78%
0.6%
27
Clinical Microbiology and Infection
60 papers in training set
Top 2%
0.6%